Where Tech Meets Bio
Subscribe
Sign in
Home
Podcast
Weekly Highlights
Deep Dives
Sponsored Features
About
How Tech Giants like NVIDIA, Google, and Microsoft Are Targeting New Niches in Biopharma R&D
Tech giants are becoming part of biopharma’s infrastructure, applying AI, data, and cloud to drug discovery as they seek footholds in new markets
Sep 26
•
Illia Terpylo
and
BiopharmaTrend
9
Weekly Tech+Bio Highlights #55: AI-Generated Functional Bacteriophages
Over $100M in funding & early clinical updates on AI drugs
Sep 23
•
Roman Kasianov
,
Illia Terpylo
, and
BiopharmaTrend
9
Weekly Tech+Bio Highlights #54: Era of Generative Genomics
Emerging Unicorn in Autonomous AI Labs, Benchmarking Scientific AI Agents, & Hitting "Undo" on Disease
Sep 16
•
BiopharmaTrend
,
Roman Kasianov
, and
Illia Terpylo
11
Latest
Top
Discussions
Biotech in Space: Microgravity, Ventures, and the Path to Production
From public labs to private stations, the near-term outlook for orbital bioprocessing and its first commercial pipelines
Sep 11
•
BiopharmaTrend
and
Illia Terpylo
8
Weekly Tech+Bio Highlights #53: Eli Lilly Opens Access to AI Models Trained on $1 Billion Worth of R&D Data
Is the first anti-aging drug class on the horizon? Also: David Baker’s new venture; grounding AI in chemistry & current state of medchem platforms
Sep 9
•
Roman Kasianov
and
Illia Terpylo
7
Weekly Tech+Bio Highlights #52: Open AI's Accelerated Cell Reprogramming
Tempus-Paige Digital Pathology Acquisition Deal, Reasoning AIs for Biology & Antibiotics
Aug 26
•
BiopharmaTrend
and
Roman Kasianov
8
Digital Pathology: Slides, AI, & Challenges
Pathology has progressed from glass slides to AI-driven digital diagnostics, promising to transform disease detection, while facing adoption and market…
Aug 14
•
Illia Terpylo
and
BiopharmaTrend
8
Weekly Tech+Bio Highlights #51: Neurosymbolic AI for Biomedical Research
$6B AI Drug Discovery Deal & FDA’s AI Lifecycle Concept for Health Care
Aug 11
•
BiopharmaTrend
and
Roman Kasianov
4
Building the Virtual Cell: AI Foundation Models and Billion-Cell Datasets
From early 2000s and a 2012 milestone to a decade-long quiet—virtual cell modeling is resurging with transformers, perturbation atlases, and…
Aug 7
•
BiopharmaTrend
and
Illia Terpylo
9
Weekly Tech+Bio Highlights #50: How Robust Are Pathology Foundation Models?
CRISPR-GPT, Current Gene Delivery Landscape, & Thought-Controlled iPad
Aug 5
•
BiopharmaTrend
and
Roman Kasianov
8
See all
Recommendations
View all 6
The Algorithmic Bridge
Alberto Romero
Noahpinion
Noah Smith
AI Supremacy
Michael Spencer
The Connected Ideas Project
Alexander Titus
People vs Algorithms
Troy Young
Where Tech Meets Bio
About
Archive
Recommendations
Sitemap
